Understanding and improving treatments for prostate cancer
SPORE in Prostate Cancer
This study is looking into how prostate cancer grows and becomes harder to treat, with the goal of finding better treatments to help men with advanced prostate cancer live longer and healthier lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10769303 on NIH RePORTER |
What this research studies
This research focuses on prostate cancer, the most common cancer diagnosed in men in the U.S. The project aims to explore the molecular mechanisms behind prostate cancer progression, particularly how changes in hormone regulation, DNA repair, and the immune environment contribute to treatment resistance. By leveraging insights gained from previous studies, the research seeks to develop more effective therapies that could improve survival rates for patients with advanced prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research include men diagnosed with advanced or metastatic prostate cancer who have not responded well to existing therapies.
Not a fit: Patients with early-stage prostate cancer or those who have not yet undergone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for prostate cancer, potentially improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promise in understanding the molecular mechanisms of prostate cancer, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Denmeade, Samuel R — Johns Hopkins University
- Study coordinator: Denmeade, Samuel R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.